Joanne Edwards

University of Glasgow

Professor Joanne Edwards obtained a BSc in Pharmacology from the University of Glasgow followed by her PhD in Cancer Biology from the University of St Andrews. She became a Fellow of the Royal College of Pathologists in 2012 (published works). Her scientific career has included working as a Clinical Scientist in Glasgow Royal Infirmary, followed by a Senior Lecture in the Institute of Cancer Sciences University of Glasgow and more recently in January this year became a Professor of Translational Cancer Pathology. Her research portfolio focuses on investigation of signal transduction mechanisms associated with the development and progression of breast, colorectal and prostate cancer. Her aim is to identify clinically relevant aberrations in the human solid tumours and establish if they can be employed in clinical practise to improve patient care and outcome.

dont miss

Role of IKK alpha in Breast Cancer

Triple negative breast cancer (TNBC) is the most aggressive subtype of breast carcinoma with limited therapeutic options. IKKα, the main catalytic kinase in the NF-κB non-canonical pathway, may be a novel therapeutic target for treatment of TNBC as elevated levels of phosphorylated IKKα in TNBC specimens is associated with reduced cancer specific survival and treatment of TNBC cell lines with IKKα inhibitors results in reduced cell viability.

EVEN MORE SEMINARS

  • Dr. Gerald Batist: Speaking at the Oncology Convention

    Dr. Gerald Batist
    Segal Cancer Centre of Jewish General Hospital

    Systemic Cancer Therapy: Achievements and Challenges that Lie Ahead

  • Professor Sun Myint: Speaking at the Oncology Convention

    Professor Sun Myint
    Clatterbridge Cancer Centre (Private Clinic)

    Rectal cancer- Do patients have a choice?

  • James Flanagan: Speaking at the Oncology Convention

    James Flanagan
    Imperial College London

    Epigenetic biomarkers for platinum response in ovarian cancer

  • Professor Hisham Mehanna: Speaking at the Oncology Convention

    Professor Hisham Mehanna
    InHANSE, Institute of Cancer and Genomic Sciences, University of Birmingham

    Clinical trials that change patient care and the lessons learnt

  • Dr. Richard Baird: Speaking at the Oncology Convention

    Dr. Richard Baird
    Cancer Research UK Cambridge Centre

    Update on Precision Medicine Approaches to Treat Metastatic Breast Cancer